“Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats”. Food and chemical toxicology46 (3). (2008). doi:10.1016/j.fct.2007.10.043. PMID18155344.
D. A. Vattem and K. Shetty (2005). “Biological Function of Ellagic Acid: A Review”. Journal of Food Biochemistry29: 234–266. doi:10.1111/j.1745-4514.2005.00031.x.
Seeram NP, Adams LS, Henning SM, et al. (June 2005). “In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice”. J. Nutr. Biochem.16 (6): 360–7. doi:10.1016/j.jnutbio.2005.01.006. PMID15936648.
Madal, Shivappurkar, Galati, and Stoner (1988). “Inhibition of N-nitrosobenzymethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid”. Carcinogenesis9 (7): 1313–1316. doi:10.1093/carcin/9.7.1313. PMID3383347.
Mandal and Stoner; Stoner, GD (1990). “Inhibition of N-nitrosobenzymethylamine-induced esophageal tumorigenesis in rats by ellagic acid”. Carcinogenesis11 (1): 55–61. doi:10.1093/carcin/11.1.55. PMID2295128.
Teel, Babcock, Dixit, and Stoner (1986). “Ellagic acid toxicity and interaction with benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in human bronchial epithelial cells”. Cell Biol. Toxicol.2 (1): 53–62. doi:10.1007/BF00117707. PMID3267445.
Meyer, A. S.; Heinonen, M.; Frankel, E. N. (1998). “Antioxidant interactions of catechin, cyanidin, caffeic acid, quercetin, and ellagic acid on human LDL oxidation”. Food Chem.61: 71-75. doi:10.1016/S0308-8146(97)00100-3.
Aviram M, Rosenblat M, Gaitini D, et al. (June 2004). “Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation”. Clin Nutr23 (3): 423–33. doi:10.1016/j.clnu.2003.10.002. PMID15158307.
Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G (April 2005). “Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate”. Eur. Urol.47 (4): 449–54; discussion 454–5. doi:10.1016/j.eururo.2004.12.001. PMID15774240.
“Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats”. Food and chemical toxicology46 (3). (2008). doi:10.1016/j.fct.2007.10.043. PMID18155344.
Seeram NP, Adams LS, Henning SM, et al. (June 2005). “In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice”. J. Nutr. Biochem.16 (6): 360–7. doi:10.1016/j.jnutbio.2005.01.006. PMID15936648.
Madal, Shivappurkar, Galati, and Stoner (1988). “Inhibition of N-nitrosobenzymethylamine metabolism and DNA binding in cultured rat esophagus by ellagic acid”. Carcinogenesis9 (7): 1313–1316. doi:10.1093/carcin/9.7.1313. PMID3383347.
Mandal and Stoner; Stoner, GD (1990). “Inhibition of N-nitrosobenzymethylamine-induced esophageal tumorigenesis in rats by ellagic acid”. Carcinogenesis11 (1): 55–61. doi:10.1093/carcin/11.1.55. PMID2295128.
Teel, Babcock, Dixit, and Stoner (1986). “Ellagic acid toxicity and interaction with benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in human bronchial epithelial cells”. Cell Biol. Toxicol.2 (1): 53–62. doi:10.1007/BF00117707. PMID3267445.
Aviram M, Rosenblat M, Gaitini D, et al. (June 2004). “Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation”. Clin Nutr23 (3): 423–33. doi:10.1016/j.clnu.2003.10.002. PMID15158307.
Falsaperla M, Morgia G, Tartarone A, Ardito R, Romano G (April 2005). “Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate”. Eur. Urol.47 (4): 449–54; discussion 454–5. doi:10.1016/j.eururo.2004.12.001. PMID15774240.
